CHALLENGE (Colon Health and Life-Long Exercise Change) clinical trial

The CHALLENGE study, led by the NCIC Clinical Trials Group (CTG) and supported by the Canadian Cancer Society, is examining whether exercise can help to prevent recurrence of colon cancer.

CHALLENGE is the first randomized trial to study whether exercise can improve cancer survival. The trial will involve colon cancer survivors who have recently completed treatment with surgery and chemotherapy. All participants will be provided with health education materials and monitored closely for cancer recurrence.

Half of the participants will work with a physical activity consultant to increase and maintain their level of activity by 150 minutes a week from what they were doing before the study. The other half of the participants can exercise if they wish but are not provided with a physical activity consultant. Each participant will be followed for three years to discover whether exercise boosts survival rates and improves quality of life.

The CHALLENGE trial will involve nearly 1,000 participants at sites across Canada and internationally, and currently nearly 300 have enrolled. If you are interested in finding out more about the CHALLENGE clinical trial, contact us at 1 888 939-3333 or or talk to your oncologist.

Read more about the CHALLENGE trial.